High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels
Authors
Keywords
-
Journal
Translational Psychiatry
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-20
DOI
10.1038/s41398-019-0633-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fatty fish intake and cognitive function: FINS-KIDS, a randomized controlled trial in preschool children
- (2018) Jannike Øyen et al. BMC Medicine
- Omega-6/omega-3 fatty acid intake of children and older adults in the U.S.: dietary intake in comparison to current dietary recommendations and the Healthy Eating Index
- (2018) Kelly W. Sheppard et al. Lipids in Health and Disease
- Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n−3 fatty acids containing phospholipids
- (2018) Nachum Vaisman et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- The Effect of Methylphenidate and Atomoxetine on Heart Rate and Systolic Blood Pressure in Young People and Adults with Attention-Deficit Hyperactivity Disorder (ADHD): Systematic Review, Meta-Analysis, and Meta-Regression
- (2018) Edwin F. Liang et al. International Journal of Environmental Research and Public Health
- Omega-3 fatty acids regulate plasticity in distinct hippocampal glutamatergic synapses
- (2018) Sanjay Aryal et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Serum Interleukin-6 Level in Children With Attention-Deficit Hyperactivity Disorder (ADHD)
- (2018) Amira Hamed Darwish et al. JOURNAL OF CHILD NEUROLOGY
- New insights on the regulation of cancer cachexia by N-3 polyunsaturated fatty acids
- (2018) Renata Gorjao et al. PHARMACOLOGY & THERAPEUTICS
- The safety of extended-release drug formulations for the treatment of ADHD
- (2017) Ann Childress Expert Opinion On Drug Safety
- Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder: a Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies
- (2017) Jane Pei-Chen Chang et al. NEUROPSYCHOPHARMACOLOGY
- Association of atopic diseases and attention-deficit/hyperactivity disorder: A systematic review and meta-analyses
- (2017) Jurjen van der Schans et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Dietary n-3 PUFA, fish consumption and depression: A systematic review and meta-analysis of observational studies
- (2016) Giuseppe Grosso et al. JOURNAL OF AFFECTIVE DISORDERS
- Diet-induced changes in iron and n-3 fatty acid status and associations with cognitive performance in 8–11-year-old Danish children: secondary analyses of the Optimal Well-Being, Development and Health for Danish Children through a Healthy New Nordic Diet School Meal Study
- (2015) Louise Bergmann Sørensen et al. BRITISH JOURNAL OF NUTRITION
- Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis
- (2015) Ruth E Cooper et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study
- (2015) M H Rapaport et al. MOLECULAR PSYCHIATRY
- Serum pro-BDNF/BDNF as a treatment biomarker for response to docosahexaenoic acid in traumatized people vulnerable to developing psychological distress: a randomized controlled trial
- (2015) Y Matsuoka et al. Translational Psychiatry
- Omega-3 Fatty Acids in the Prevention of Interferon-Alpha-Induced Depression: Results from a Randomized, Controlled Trial
- (2014) Kuan-Pin Su et al. BIOLOGICAL PSYCHIATRY
- Parent preferences regarding stimulant therapies for ADHD: a comparison across six European countries
- (2014) Beenish Nafees et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Correlation between n-3 polyunsaturated fatty acids consumption and BDNF peripheral levels in adolescents
- (2014) Charles Ferreira et al. Lipids in Health and Disease
- G-Protein Signaling, Lipid Rafts and the Possible Sites of Action for the Antidepressant Effects of n-3 Polyunsaturated Fatty Acids
- (2013) Andrew Czysz et al. CNS & Neurological Disorders-Drug Targets
- Omega-3 polyunsaturated fatty acids for major depressive disorder
- (2013) Kuan-Pin Su et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Increased Erythrocyte Eicosapentaenoic Acid and Docosahexaenoic Acid Are Associated With Improved Attention and Behavior in Children With ADHD in a Randomized Controlled Three-Way Crossover Trial
- (2013) Catherine M. Milte et al. Journal of Attention Disorders
- Changes in plasma Brain-derived neurotrophic factor (BDNF) levels induced by methylphenidate in children with Attention deficit–hyperactivity disorder (ADHD)
- (2013) Ali Amiri et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Changes in the serum levels of brain-derived neurotrophic factor in adults with attention deficit hyperactivity disorder after treatment with atomoxetine
- (2013) Josep Antoni Ramos-Quiroga et al. PSYCHOPHARMACOLOGY
- Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation and severity of depression
- (2012) P-Y Lin et al. MOLECULAR PSYCHIATRY
- A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
- (2012) Charles L. Raison et al. JAMA Psychiatry
- The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: A double-blind placebo-controlled trial, followed by an open-label extension
- (2011) I. Manor et al. EUROPEAN PSYCHIATRY
- Omega-3 Fatty Acid Supplementation for the Treatment of Children With Attention-Deficit/Hyperactivity Disorder Symptomatology: Systematic Review and Meta-Analysis
- (2011) Michael H. Bloch et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Supplementation with Eicosapentaenoic Omega-3 Fatty Acid Does Not Influence Serum Brain-Derived Neurotrophic Factor in Diabetes Mellitus Patients with Major Depression: A Randomized Controlled Pilot Study
- (2011) Mariska Bot et al. NEUROPSYCHOBIOLOGY
- Phospholipase A2 and Cyclooxygenase 2 Genes Influence the Risk of Interferon-α–Induced Depression by Regulating Polyunsaturated Fatty Acids Levels
- (2009) Kuan-Pin Su et al. BIOLOGICAL PSYCHIATRY
- A Double-Blind, Randomized Controlled Trial of Ethyl-Eicosapentaenoate for Major Depressive Disorder
- (2009) David Mischoulon et al. JOURNAL OF CLINICAL PSYCHIATRY
- Genetic Variants of the FADS1 FADS2 Gene Cluster Are Associated with Altered (n-6) and (n-3) Essential Fatty Acids in Plasma and Erythrocyte Phospholipids in Women during Pregnancy and in Breast Milk during Lactation
- (2008) Lin Xie et al. JOURNAL OF NUTRITION
- Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: A randomised controlled trial
- (2008) N. Sinn et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started